ID

31398

Description

A Pharmacokinetic Study of Subcutaneous and Intravenous MabThera (Rituximab) in Patients With Follicular Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00930514

Lien

https://clinicaltrials.gov/show/NCT00930514

Mots-clés

  1. 19/08/2018 19/08/2018 -
Détendeur de droits

see clinicaltrials.gov

Téléchargé le

19 août 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Lymphoma, Follicular NCT00930514

Eligibility Lymphoma, Follicular NCT00930514

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult patients, >=18 years of age;
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
cd20-positive follicular non-hodgkin's lymphoma (nhl);
Description

Lymphoma, Non-Hodgkin; Lymphoma, Follicular; CD20 antigen positive

Type de données

boolean

Alias
UMLS CUI [1,1]
C0024305
UMLS CUI [1,2]
C0024301
UMLS CUI [1,3]
C3888518
partial or complete response a the end of induction treatment with mabthera;
Description

partial response | Complete therapeutic response | Induction Chemotherapy; Mabthera

Type de données

boolean

Alias
UMLS CUI [1]
C1521726
UMLS CUI [2]
C1275810
UMLS CUI [3,1]
C3179010
UMLS CUI [3,2]
C1314901
must have completed induction treatment, and received >= 1 dose of iv mabthera maintenance treatment;
Description

Induction Chemotherapy; Complete | Maintenance therapy; Mabthera; Intravenous

Type de données

boolean

Alias
UMLS CUI [1,1]
C3179010
UMLS CUI [1,2]
C0205197
UMLS CUI [2,1]
C0677908
UMLS CUI [2,2]
C1314901
UMLS CUI [2,3]
C0348016
ecog performance status of <=2.
Description

ECOG performance status

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
histological evidence of transformation of nhl, or types of nhl other than follicular lymphoma;
Description

Lymphoma, Non-Hodgkin; cell transformation | Lymphoma, Follicular

Type de données

boolean

Alias
UMLS CUI [1,1]
C0024305
UMLS CUI [1,2]
C0040682
UMLS CUI [2]
C0024301
presence or history of cns disease;
Description

CNS disorder

Type de données

boolean

Alias
UMLS CUI [1]
C0007682
history of malignancy other than follicular nhl which could affect compliance with protocol or interpretation of results;
Description

Malignant Neoplasms | Lymphoma, Non-Hodgkin; Lymphoma, Follicular | Protocol Compliance | Interpretation of results

Type de données

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C0024305
UMLS CUI [2,2]
C0024301
UMLS CUI [3]
C0525058
UMLS CUI [4]
C3526596
recent major surgery (within 4 weeks prior to screening, excluding lymph node biopsy).
Description

major surgery; Time | Biopsy of lymph node; Exclude

Type de données

boolean

Alias
UMLS CUI [1,1]
C0679637
UMLS CUI [1,2]
C0040223
UMLS CUI [2,1]
C0193842
UMLS CUI [2,2]
C0332196

Similar models

Eligibility Lymphoma, Follicular NCT00930514

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
adult patients, >=18 years of age;
boolean
C0001779 (UMLS CUI [1])
Lymphoma, Non-Hodgkin; Lymphoma, Follicular; CD20 antigen positive
Item
cd20-positive follicular non-hodgkin's lymphoma (nhl);
boolean
C0024305 (UMLS CUI [1,1])
C0024301 (UMLS CUI [1,2])
C3888518 (UMLS CUI [1,3])
partial response | Complete therapeutic response | Induction Chemotherapy; Mabthera
Item
partial or complete response a the end of induction treatment with mabthera;
boolean
C1521726 (UMLS CUI [1])
C1275810 (UMLS CUI [2])
C3179010 (UMLS CUI [3,1])
C1314901 (UMLS CUI [3,2])
Induction Chemotherapy; Complete | Maintenance therapy; Mabthera; Intravenous
Item
must have completed induction treatment, and received >= 1 dose of iv mabthera maintenance treatment;
boolean
C3179010 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C0677908 (UMLS CUI [2,1])
C1314901 (UMLS CUI [2,2])
C0348016 (UMLS CUI [2,3])
ECOG performance status
Item
ecog performance status of <=2.
boolean
C1520224 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Lymphoma, Non-Hodgkin; cell transformation | Lymphoma, Follicular
Item
histological evidence of transformation of nhl, or types of nhl other than follicular lymphoma;
boolean
C0024305 (UMLS CUI [1,1])
C0040682 (UMLS CUI [1,2])
C0024301 (UMLS CUI [2])
CNS disorder
Item
presence or history of cns disease;
boolean
C0007682 (UMLS CUI [1])
Malignant Neoplasms | Lymphoma, Non-Hodgkin; Lymphoma, Follicular | Protocol Compliance | Interpretation of results
Item
history of malignancy other than follicular nhl which could affect compliance with protocol or interpretation of results;
boolean
C0006826 (UMLS CUI [1])
C0024305 (UMLS CUI [2,1])
C0024301 (UMLS CUI [2,2])
C0525058 (UMLS CUI [3])
C3526596 (UMLS CUI [4])
major surgery; Time | Biopsy of lymph node; Exclude
Item
recent major surgery (within 4 weeks prior to screening, excluding lymph node biopsy).
boolean
C0679637 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
C0193842 (UMLS CUI [2,1])
C0332196 (UMLS CUI [2,2])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial